Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $476.37 | 26 | 67.6% |
| Education | $228.73 | 4 | 32.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $142.15 | 5 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $126.63 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $113.24 | 8 | $0 (2021) |
| Allergan, Inc. | $82.43 | 5 | $0 (2020) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $68.40 | 2 | $0 (2022) |
| ABBVIE INC. | $65.85 | 4 | $0 (2024) |
| ITI, Inc. | $48.84 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $34.59 | 2 | $0 (2018) |
| Alkermes, Inc. | $22.97 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.71 | 2 | Teva Pharmaceuticals USA, Inc. ($111.49) |
| 2023 | $81.47 | 3 | ITI, Inc. ($48.84) |
| 2022 | $68.40 | 2 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($68.40) |
| 2021 | $97.76 | 7 | Sunovion Pharmaceuticals Inc. ($43.85) |
| 2020 | $150.11 | 9 | Sunovion Pharmaceuticals Inc. ($69.39) |
| 2019 | $90.10 | 1 | Janssen Pharmaceuticals, Inc ($90.10) |
| 2018 | $56.61 | 4 | Otsuka America Pharmaceutical, Inc. ($16.47) |
| 2017 | $34.94 | 2 | Otsuka America Pharmaceutical, Inc. ($18.12) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 01/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $48.84 | General |
| Category: PSYCHIATRY | ||||||
| 03/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2022 | Otsuka Pharmaceutical Development & Commercialization, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $45.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2022 | Otsuka Pharmaceutical Development & Commercialization, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $23.40 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Neuroscience | ||||||
| 06/09/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: CNS | ||||||
| 04/29/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: CNS | ||||||
| 04/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: CNS | ||||||
| 02/18/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CNS | ||||||
| 01/14/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: CNS | ||||||
| 12/10/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: CNS | ||||||
| 11/12/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: CNS | ||||||
| 11/03/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CNS | ||||||
| 10/22/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: CNS | ||||||
| 09/28/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Neuroscience | ||||||
| 04/18/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $90.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/13/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 282 | $46,290 | $26,740 |
| 2022 | 2 | 46 | 423 | $69,030 | $44,195 |
| 2021 | 3 | 76 | 323 | $55,015 | $34,835 |
| 2020 | 4 | 62 | 209 | $35,665 | $20,299 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 21 | 204 | $32,640 | $20,515 | 62.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 78 | $13,650 | $6,225 | 45.6% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 19 | 333 | $53,280 | $36,307 | 68.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 90 | $15,750 | $7,888 | 50.1% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 26 | 205 | $32,765 | $23,219 | 70.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 96 | $16,750 | $8,565 | 51.1% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2021 | 22 | 22 | $5,500 | $3,051 | 55.5% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 11 | 129 | $20,640 | $14,094 | 68.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 51 | $6,375 | $2,726 | 42.8% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2020 | 15 | 16 | $4,100 | $1,860 | 45.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 13 | 13 | $4,550 | $1,619 | 35.6% |
About Dr. Scott Wright, M.D
Dr. Scott Wright, M.D is a Psychiatry healthcare provider based in Quincy, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447258181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Wright, M.D has received a total of $705.10 in payments from pharmaceutical and medical device companies, with $125.71 received in 2024. These payments were reported across 30 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($476.37).
As a Medicare-enrolled provider, Wright has provided services to 231 Medicare beneficiaries, totaling 1,237 services with total Medicare billing of $126,069. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Quincy, IL
- Active Since 07/07/2005
- Last Updated 09/18/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1447258181
Products in Payments
- VRAYLAR (Drug) $148.28
- LATUDA (Drug) $113.24
- INVOKANA (Drug) $90.10
- ABILIFY MAINTENA (Drug) $68.40
- INVEGA SUSTENNA (Drug) $52.05
- CAPLYTA (Drug) $48.84
- REXULTI (Drug) $34.59
- VIVITROL (Drug) $22.97
- AUSTEDO (Drug) $15.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Quincy
Dr. Alexandra Accardi, Md, MD
Psychiatry — Payments: $3,546
Salvador Sanchez-Zuniga, Md, MD
Psychiatry — Payments: $2,464
Jonathan Love
Psychiatry — Payments: $1,941
Lani Nicholson, M.d, M.D
Psychiatry — Payments: $957.79
Richard Reiner, M.d, M.D
Psychiatry — Payments: $707.55
Dr. Stephen Dubin, Do, DO
Psychiatry — Payments: $496.90